Five‐year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project

Clinical and Experimental Ophthalmology - Tập 31 Số 5 - Trang 397-402 - 2003
Daniel J. McCarty1,2, Catherine A. McCarty1, C Alex Harper1, Hugh R. Taylor1
1Centre for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia and
2Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA

Tóm tắt

Abstract Background: The purpose of the present paper was to describe the 5‐year incidence and progression of diabetic retinopathy in the Melbourne Visual Impairment Project (VIP) cohort. Methods: Baseline examinations were conducted from 1992 to 1994 and follow‐up data were collected 5 years later. Data collected during the baseline and follow‐up studies included medical history (including previous diag­nosis of diabetes mellitus) and dilated fundus examination. Two 30° stereoscopic fundus photographs were taken with a Topcon TRC fundus camera, one centred on the optic disc and the other centred on the fovea. Photographs from participants who reported having diabetes were graded for diabetic retinopathy based on an extension of the Modified Airlie House Classification. Grouping of participant data into retinopathy grades was based on the results of the worst eye. Results: The follow‐up survey included 82% (n = 121) of those with diabetes at baseline. Prevalence of any retino­pathy was 35.7% and macular oedema was 13% at follow up. Diabetic retinopathy was newly detected in 8/73 (5‐year incidence = 11.0%, 95% confidence interval (CI) = 3.8−18.1). Disease progression was seen in 9/31 participants (29.0%, 95%CI = 14.9−47.8) who had diabetic retinopathy at baseline. The 5‐year incidence of proliferative diabetic retino­pathy in people without proliferative diabetic retinopathy at baseline was 2.9% (3/104, 95%CI = 0−6.4). The 5‐year incidence of macular oedema in people who did not have macular oedema at baseline was 8.0% (8/100, 95%CI = 2.7−13.3). All people with proliferative diabetic retinopathy at baseline had received laser treatment by the follow‐up survey. Twenty‐four per cent of people without diabetic retinopathy reported never having had a dilated fundus examination (excluding the VIP examinations). Conclusion: The 5‐year incidence of diabetic retinopathy was 11% in the Melbourne Visual Impairment Project. Most people with proliferative diabetic retinopathy or macular oedema are receiving treatment. However, many people with diabetes are not having regular dilated fundus examinations.

Từ khóa


Tài liệu tham khảo

10.1111/j.1442-9071.1985.tb00397.x

10.1001/archopht.1989.01070010250031

10.1016/S0161-6420(89)32699-6

10.1111/j.1464-5491.1994.tb00271.x

10.1093/ije/24.4.787

10.2337/diacare.8.4.316

10.1111/j.1464-5491.1991.tb01532.x

10.2337/diacare.9.3.313b

10.2337/diacare.9.4.334

10.1001/jama.1988.03410190112033

10.1016/S0161-6420(13)31517-6

10.2337/diab.44.8.968

10.2337/diacare.10.1.20

10.2337/diacare.11.3.246

10.1136/bmj.317.7160.703

Klein R, 1989, Is high blood pressure a predictor of the incidence or progression of diabetic retinopathy?, Arch Intern Med, 149, 2427, 10.1001/archinte.1989.00390110033008

10.1136/bmj.288.6423.1035

10.1016/S0161-6420(98)91227-1

10.1136/bjo.84.8.865

10.3109/09286589409047222

Early Treatment of Diabetic Retinopathy Study Research Group., 1991, Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the Modified Airlie House Classification. ETDRS Report Number 10, Ophthalmology, 98, 786, 10.1016/S0161-6420(13)38012-9

10.1136/bmj.321.7258.405

10.1136/bjo.82.4.410

National Health and Medical Research Council., 1997, Management of Diabetic Retinopathy. Clinical Practice Guidelines